HROW up 8%. A closer look at the stock:

 Shares of Harrow Health Inc (HROW) are trading 8% higher at a price of $9.285 at the time of this writing. The Health Care sector is having a generally slightly somber day, this hasn't really affected the stock's share price, as it quickly outmatching other names in the space.

The company recently announced mixed earnings, with an EPS miss and a revenue beat. This doesn't seem to be phasing traders however, as they lap up shares despite the broad market selloff - a strong bullish signal.

Harrow Health Inc has been trading between a 52-week high of $12.99 and a 52-week low of $5.4. The stock has a market cap of $251 Million.

Harrow Health, Inc. owns a portfolio of ophthalmic pharmaceutical businesses, including ImprimisRx, the nation's leading ophthalmology outsourcing facility and pharmaceutical compounding business. The company holds large equity positions in Eton Pharmaceuticals, Surface Ophthalmics, and Melt Pharmaceuticals.